Stem Cells & Perinatal Therapies
Cell and perinatal products: promise, evidence, quality and clinical limitations.
Browse by collection
Explore interactive learning ↗Interactive cases & learning
A selection of published cases and interactive modules is shown below. Open the section title to browse the full directory.
-
Monkey Dance World Tour
-
Vasculitis VIII · CNS vasculitis, neuropathy, secondary vasculitis and VEXAS · Clinical Rounds
-
Vasculitis X · Treatment safety and evidence · Clinical Rounds
-
Vasculitis IX · Rheumatic emergencies · Clinical Rounds
-
Vasculitis VII · Behçet disease and Cogan syndrome · Clinical Rounds
-
Vasculitis V · Polyarteritis nodosa, DADA2, and Kawasaki disease · Clinical Rounds
-
Vasculitis IV · Eosinophilic granulomatosis with polyangiitis and anti-GBM disease · Clinical Rounds
-
Vasculitis III · Granulomatosis with polyangiitis and microscopic polyangiitis · Clinical Rounds
-
Vasculitis II · Giant cell arteritis, polymyalgia rheumatica, and Takayasu arteritis · Clinical Rounds
-
Vasculitis I · Recognizing vasculitis and its mimics · Clinical Rounds
-
Small Fall, Big Deal — RheumaPlay
Rheumatology in Perspective
Library
Search by topic, condition or question
94 materials
Clear filtersInteractive · Psoriatic arthritis
Heart, sugar, liver: PsA’s travel companions
Inflammation doesn’t stay in the joints. Four doors about the conditions that like to travel with PsA — and how to keep them in check.
Reviewed
Interactive · Psoriatic arthritis
Detective work: how PsA is diagnosed
You are the doctor for a day. The budget is limited — choose the tests that really help.
Reviewed
In Depth · Spondyloarthritis (SpA)
PsA research directions: what is changing and what remains open
A dated reading selection on tissue biology, new treatment designs, molecular prediction and interception. Each entry separates the published evidence from the next question.
In Depth · Spondyloarthritis (SpA)
Reading PsA studies: endpoints, comparisons and meaningful benefit
Learn to translate a headline into a question you can examine: who was studied, what improved, compared with what, by how much and for how long?
In Depth · Spondyloarthritis (SpA)
PsA biomarkers: what tests can tell us—and what they cannot
A biomarker becomes useful when it answers a defined question. Distinguish a measure of inflammation from a test that diagnoses disease, predicts its course or helps choose between treatments.
In Depth · Spondyloarthritis (SpA)
From psoriasis to PsA: risk, early signs and prevention
How to think about future arthritis without treating a risk factor as a diagnosis. The aim is to recognise a meaningful change early and understand what prevention studies are testing.
In Depth · Spondyloarthritis (SpA)
PsA mechanisms: tissues, immune signals and bone
Follow inflammation from the tissue where symptoms arise to the signals that targeted treatments interrupt. A useful model of psoriatic arthritis leaves room for differences between skin, joints and the spine.
In Depth · Spondyloarthritis (SpA)
PsA with a complex medical history: decisions across specialties
Cancer, serious infections, liver or kidney disease, bowel inflammation and uveitis can change a PsA treatment discussion. The useful question is what each condition changes for this person, now.
In Depth · Spondyloarthritis (SpA)
PsA in later life: several conditions, one workable plan
When psoriatic arthritis shares the picture with other conditions, the aim is to control inflammation while keeping treatment practical and preserving what matters in daily life.
In Depth · Spondyloarthritis (SpA)
PsA in adolescence: moving into adult care
A successful transition keeps treatment, monitoring and everyday life connected while a young person gradually takes a larger role in their care.
In Depth · Spondyloarthritis (SpA)
PsA: family planning, pregnancy and breastfeeding
Planning a family involves more than a list of permitted medicines. Make room for disease control, fertility, feeding choices and the practical demands of caring for a baby.
Interactive · Early autoimmunity
Psoriasis and Joint Symptoms: Recognising Early PsA
This pathway relies on symptoms, examination and imaging — not on a single antibody test.
Reviewed